Earnings History Data for Arena Pharmaceuticals, Inc. (ARNA) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Arena Pharmaceuticals, Inc.

Arena Pharmaceuticals is a biopharmaceutical company focused on discovering, developing and commercializing novel drugs that target G protein-coupled receptors, or GPCRs, to address unmet medical needs. BELVIQ (lorcaserin HCl), their internally discovered drug for chronic weight management, is their first and only drug approved by any regulatory agency for marketing. BELVIQ was approved by the US Food and Drug Administration, or FDA, for marketing in the United States, and was made available by prescription in June 2013 to adults who are overweight with a comorbidity or obese. They are exploring BELVIQ for possible new indications, using different formulations, and in combination with other drugs.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
23-02-2022 AH 4:05 PM ET
(Feb 23)
ARNA Arena Pharmaceuticals, Inc. 5,730 -2.54 -2.41 -2.10 Arena Pharmaceuticals GAAP EPS of -$2.54 misses by $0.31
[2/23/2022 4:09 PM]
94.05 0.06 
(0.06%)
93.77 -0.22 
(-0.24%)
45.50 - 94.50 679,070 1,579,893 698,809
04-11-2021 AH 4:05 PM ET
(Nov 4)
ARNA Arena Pharmaceuticals, Inc. 3,650 -3.21 -2.42 -1.69 Arena Pharmaceuticals EPS misses by $0.74
[11/4/2021 4:24 PM]
60.83 -2.17 
(-3.44%)
63.00 0.0 
(0.00%)
45.50 - 90.16 512,035 760,000 7,002
05-08-2021 AH 4:05 PM ET
(Aug 5)
ARNA Arena Pharmaceuticals, Inc. 3,670 -2.40 -2.21 -1.61 Arena Pharmaceuticals EPS misses by $0.22
[8/5/2021 4:13 PM]
55.25 -6.85 
(-11.03%)
62.10 0.0 
(0.00%)
53.51 - 90.19 1,282,093 470,000 8,817
05-05-2021 AH 4:05 PM ET
(May 5)
ARNA Arena Pharmaceuticals, Inc. 4,140 -1.98 -2.19 2.00 Arena Pharmaceuticals EPS beats by $0.20
[5/5/2021 4:14 PM]
63.07 -1.23 
(-1.91%)
64.30 0.0 
(0.00%)
44.79 - 90.19 543,089 480,000 49,242
23-02-2021 AH 4:05 PM ET
(Feb 23)
ARNA Arena Pharmaceuticals, Inc. 4,720 -2.10 -1.97 -1.76 Arena Pharmaceuticals EPS misses by $0.27
[2/23/2021 4:07 PM]
79.90 3.34 
(4.36%)
76.56 0.0 
(0.00%)
32.95 - 90.19 610,026 442,124 8,916
09-11-2020 AH 4:00 PM ET
(Nov 9)
ARNA Arena Pharmaceuticals, Inc. 4,970 -1.69 -1.92 -1.46 Arena Pharmaceuticals EPS beats by $0.18, misses on revenue
[11/9/2020 4:11 PM]
69.96 -17.45 
(-19.97%)
70.24 -17.18 
(-19.65%)
32.95 - 90.19 5,125,821 804,410 16,154
05-08-2020 AH 4:00 PM ET
(Aug 5)
ARNA Arena Pharmaceuticals, Inc. 3,480 -1.61 -2.08 -1.24 Arena Pharmaceuticals EPS beats by $0.43
[8/5/2020 4:05 PM]
65.26 0.83 
(1.29%)
64.43 0.0 
(0.00%)
32.95 - 69.75 244,800 533,459 64,268